Skip to content
Trial Eligibility
Menu

Family Study of Lymphoproliferative Disorders

NCT00626496

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Blood and lymph node cancers can begin in either the lymphatic tissues (as in the case of lymphoma) or in the bone marrow (as with leukemia and myeloma), and they all are involved with the uncontrolled growth of white blood cells. There are many subtypes of these cancers, e.g., chronic lymphocytic leukemia and non-Hodgkin lymphoma. Since there is evidence that these cancers cluster in families, this study aims to understand how genetics and environmental exposures contribute to the development of these cancers.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Lymphoma, Non-Hodgkin
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Lymphoma, B-Cell
  • Monoclonal B-Cell Lymphocytosis
  • Multiple Myeloma

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 to 100 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Mayo Clinic
Last updated on ClinicalTrials.gov
October 14, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Minnesota · 1

  • Mayo Clinic · Rochester, MN

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.